Tag Archives: Philip Morris

FDA Authorizes Marketing of IQOS as a Modified Risk Tobacco Product

FDA Authorizes Marketing of IQOS as a Modified Risk Tobacco Product

Dubai, UAE – 8/7/2020– The U.S. Food and Drug Administration (FDA) today authorized the marketing of IQOS, Philip Morris International’s (PMI) electrically heated tobacco system, as a modified risk tobacco product (MRTP). In doing so, the agency found that an IQOS exposure modification order is appropriate to promote the public health.

Continue reading FDA Authorizes Marketing of IQOS as a Modified Risk Tobacco Product